PTH and chronic kidney disease: Oversuppression of parathyroid hormone is a concern in patients with stage 3–4 CKD treated with calcitriol or active analogues because low parathyroid hormone concentration is associated with adynamic bone disease and hypercalcaemia [26, 36].